US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist
  • 1.910
  • -0.030-1.55%
Close Dec 13 16:00 ET
  • 1.840
  • -0.070-3.66%
Post 19:51 ET
172.96MMarket Cap-1.15P/E (TTM)

Caribou Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-13.45%-32.66M
-116.44%-32.87M
-33.16%-37.2M
-2.56%-93.29M
14.63%-21.38M
-28.66%-28.79M
30.58%-15.19M
-28.91%-27.94M
-179.73%-90.97M
-17.09%-25.04M
Net income from continuing operations
-246.77%-34.68M
-27.70%-37.7M
-47.03%-41.23M
-2.66%-102.07M
-27.85%-34.51M
62.46%-10M
-10.57%-29.52M
-46.92%-28.04M
-48.56%-99.42M
-46.05%-26.99M
Operating gains losses
----
----
----
---34K
--0
--0
--0
---34K
----
----
Depreciation and amortization
-25.46%1.18M
38.74%856K
20.54%710K
117.32%3.53M
46.25%740K
250.89%1.58M
72.35%617K
91.23%589K
64.84%1.62M
85.35%506K
Other non cash items
21.02%806K
-1,744.97%-2.78M
561.92%1.72M
21,933.33%3.28M
415.48%2.18M
-70.12%666K
151.37%169K
121.24%260K
-100.62%-15K
67.98%-691K
Change In working capital
87.20%-2.82M
-76.33%2.86M
64.06%-849K
-74.07%-7.32M
4,025.00%5.02M
-3,021.50%-22.07M
595.17%12.09M
53.76%-2.36M
-114.46%-4.2M
95.18%-128K
-Change in receivables
118.15%253K
-36.64%697K
236.87%245K
-76.73%805K
284.94%1.28M
-294.42%-1.39M
238.46%1.1M
-108.58%-179K
216.77%3.46M
198.52%332K
-Change in prepaid assets
82.31%-266K
9.36%596K
-141.86%-758K
281.13%1.77M
43.26%914K
-18.80%-1.5M
-42.57%545K
239.74%1.81M
75.88%-975K
149.69%638K
-Change in payables and accrued expense
-52.67%1.1M
-38.80%2.6M
119.58%516K
1,084.64%7.56M
306.85%3.63M
197.82%2.33M
84.17%4.25M
44.46%-2.64M
-114.17%-768K
414.84%891K
-Change in other current assets
-1,983.89%-3.11M
178.95%159K
-437.10%-209K
91.49%-48K
91.13%-18K
-325.71%-149K
-64.60%57K
112.73%62K
-78.48%-564K
-23.03%-203K
-Change in other current liabilities
-167.73%-149K
-96.28%-369K
115.79%51K
-52.39%-637K
-179.03%-346K
326.80%220K
-80.77%-188K
-247.31%-323K
-158.02%-418K
11.43%-124K
-Change in other working capital
96.95%-658K
-112.97%-821K
36.74%-694K
-239.46%-16.77M
74.19%-429K
-2,572.61%-21.57M
433.40%6.33M
-91.78%-1.1M
-115.87%-4.94M
-271.81%-1.66M
Cash from discontinued investing activities
Operating cash flow
-13.45%-32.66M
-116.44%-32.87M
-33.16%-37.2M
-2.56%-93.29M
14.63%-21.38M
-28.66%-28.79M
30.58%-15.19M
-28.91%-27.94M
-179.73%-90.97M
-17.09%-25.04M
Investing cash flow
Cash flow from continuing investing activities
138.73%26.52M
91.61%21.2M
10.88%22.96M
26.88%-68.18M
-2,790.09%-31.47M
-721.15%-68.48M
179.18%11.06M
128.71%20.7M
47.14%-93.25M
100.67%1.17M
Net PPE purchase and sale
51.64%-2.3M
12.22%-2.24M
28.71%-1.45M
-79.93%-11.61M
-29.60%-2.28M
-250.96%-4.75M
2.56%-2.55M
-180.91%-2.03M
-204.29%-6.45M
-156.50%-1.76M
Net intangibles purchase and sale
----
---125K
---1.5M
--0
----
----
--0
--0
40.00%-600K
---300K
Net investment purchase and sale
142.67%27.19M
73.06%23.57M
13.94%25.9M
34.37%-56.57M
-1,004.77%-29.2M
-853.24%-63.72M
219.94%13.62M
131.85%22.73M
50.26%-86.2M
101.86%3.23M
Cash from discontinued investing activities
Investing cash flow
138.73%26.52M
91.61%21.2M
10.88%22.96M
26.88%-68.18M
-2,790.09%-31.47M
-721.15%-68.48M
179.18%11.06M
128.71%20.7M
47.14%-93.25M
100.67%1.17M
Financing cash flow
Cash flow from continuing financing activities
-99.82%244K
-99.25%132K
660.35%12.49M
7,133.85%154.3M
-133.86%-43K
20,561.77%135.13M
4,753.87%17.57M
65.86%1.64M
-99.51%2.13M
-72.39%127K
Net common stock issuance
-99.82%244K
-96.14%669K
908.82%11.33M
--152.72M
---113K
--134.38M
--17.34M
--1.12M
--0
--0
Proceeds from stock option exercised by employees
--0
-327.54%-537K
122.74%1.16M
-26.02%1.58M
-44.88%70K
15.14%753K
-34.81%236K
-47.58%519K
-16.39%2.13M
-72.39%127K
Cash from discontinued financing activities
Financing cash flow
-99.82%244K
-99.25%132K
660.35%12.49M
7,133.85%154.3M
-133.86%-43K
20,561.77%135.13M
4,753.87%17.57M
65.86%1.64M
-99.51%2.13M
-72.39%127K
Net cash flow
Beginning cash position
-42.77%37.91M
-6.33%49.45M
-12.29%51.21M
-75.72%58.38M
26.75%104.1M
-40.96%66.24M
-64.25%52.79M
-75.72%58.38M
1,407.34%240.47M
-81.13%82.13M
Current changes in cash
-115.57%-5.9M
-185.75%-11.53M
68.50%-1.76M
96.06%-7.18M
-122.75%-52.9M
225.96%37.86M
137.90%13.45M
93.97%-5.59M
-181.10%-182.08M
87.82%-23.75M
End cash Position
-69.25%32.02M
-42.77%37.91M
-6.33%49.45M
-12.29%51.21M
-12.29%51.21M
26.75%104.1M
-40.96%66.24M
-64.25%52.79M
-75.72%58.38M
-75.72%58.38M
Free cash flow
0.61%-33.33M
-98.62%-35.23M
-33.97%-40.15M
-7.02%-104.9M
12.71%-23.66M
-39.58%-33.54M
27.58%-17.74M
-33.82%-29.97M
-175.03%-98.02M
-22.77%-27.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -13.45%-32.66M-116.44%-32.87M-33.16%-37.2M-2.56%-93.29M14.63%-21.38M-28.66%-28.79M30.58%-15.19M-28.91%-27.94M-179.73%-90.97M-17.09%-25.04M
Net income from continuing operations -246.77%-34.68M-27.70%-37.7M-47.03%-41.23M-2.66%-102.07M-27.85%-34.51M62.46%-10M-10.57%-29.52M-46.92%-28.04M-48.56%-99.42M-46.05%-26.99M
Operating gains losses ---------------34K--0--0--0---34K--------
Depreciation and amortization -25.46%1.18M38.74%856K20.54%710K117.32%3.53M46.25%740K250.89%1.58M72.35%617K91.23%589K64.84%1.62M85.35%506K
Other non cash items 21.02%806K-1,744.97%-2.78M561.92%1.72M21,933.33%3.28M415.48%2.18M-70.12%666K151.37%169K121.24%260K-100.62%-15K67.98%-691K
Change In working capital 87.20%-2.82M-76.33%2.86M64.06%-849K-74.07%-7.32M4,025.00%5.02M-3,021.50%-22.07M595.17%12.09M53.76%-2.36M-114.46%-4.2M95.18%-128K
-Change in receivables 118.15%253K-36.64%697K236.87%245K-76.73%805K284.94%1.28M-294.42%-1.39M238.46%1.1M-108.58%-179K216.77%3.46M198.52%332K
-Change in prepaid assets 82.31%-266K9.36%596K-141.86%-758K281.13%1.77M43.26%914K-18.80%-1.5M-42.57%545K239.74%1.81M75.88%-975K149.69%638K
-Change in payables and accrued expense -52.67%1.1M-38.80%2.6M119.58%516K1,084.64%7.56M306.85%3.63M197.82%2.33M84.17%4.25M44.46%-2.64M-114.17%-768K414.84%891K
-Change in other current assets -1,983.89%-3.11M178.95%159K-437.10%-209K91.49%-48K91.13%-18K-325.71%-149K-64.60%57K112.73%62K-78.48%-564K-23.03%-203K
-Change in other current liabilities -167.73%-149K-96.28%-369K115.79%51K-52.39%-637K-179.03%-346K326.80%220K-80.77%-188K-247.31%-323K-158.02%-418K11.43%-124K
-Change in other working capital 96.95%-658K-112.97%-821K36.74%-694K-239.46%-16.77M74.19%-429K-2,572.61%-21.57M433.40%6.33M-91.78%-1.1M-115.87%-4.94M-271.81%-1.66M
Cash from discontinued investing activities
Operating cash flow -13.45%-32.66M-116.44%-32.87M-33.16%-37.2M-2.56%-93.29M14.63%-21.38M-28.66%-28.79M30.58%-15.19M-28.91%-27.94M-179.73%-90.97M-17.09%-25.04M
Investing cash flow
Cash flow from continuing investing activities 138.73%26.52M91.61%21.2M10.88%22.96M26.88%-68.18M-2,790.09%-31.47M-721.15%-68.48M179.18%11.06M128.71%20.7M47.14%-93.25M100.67%1.17M
Net PPE purchase and sale 51.64%-2.3M12.22%-2.24M28.71%-1.45M-79.93%-11.61M-29.60%-2.28M-250.96%-4.75M2.56%-2.55M-180.91%-2.03M-204.29%-6.45M-156.50%-1.76M
Net intangibles purchase and sale -------125K---1.5M--0----------0--040.00%-600K---300K
Net investment purchase and sale 142.67%27.19M73.06%23.57M13.94%25.9M34.37%-56.57M-1,004.77%-29.2M-853.24%-63.72M219.94%13.62M131.85%22.73M50.26%-86.2M101.86%3.23M
Cash from discontinued investing activities
Investing cash flow 138.73%26.52M91.61%21.2M10.88%22.96M26.88%-68.18M-2,790.09%-31.47M-721.15%-68.48M179.18%11.06M128.71%20.7M47.14%-93.25M100.67%1.17M
Financing cash flow
Cash flow from continuing financing activities -99.82%244K-99.25%132K660.35%12.49M7,133.85%154.3M-133.86%-43K20,561.77%135.13M4,753.87%17.57M65.86%1.64M-99.51%2.13M-72.39%127K
Net common stock issuance -99.82%244K-96.14%669K908.82%11.33M--152.72M---113K--134.38M--17.34M--1.12M--0--0
Proceeds from stock option exercised by employees --0-327.54%-537K122.74%1.16M-26.02%1.58M-44.88%70K15.14%753K-34.81%236K-47.58%519K-16.39%2.13M-72.39%127K
Cash from discontinued financing activities
Financing cash flow -99.82%244K-99.25%132K660.35%12.49M7,133.85%154.3M-133.86%-43K20,561.77%135.13M4,753.87%17.57M65.86%1.64M-99.51%2.13M-72.39%127K
Net cash flow
Beginning cash position -42.77%37.91M-6.33%49.45M-12.29%51.21M-75.72%58.38M26.75%104.1M-40.96%66.24M-64.25%52.79M-75.72%58.38M1,407.34%240.47M-81.13%82.13M
Current changes in cash -115.57%-5.9M-185.75%-11.53M68.50%-1.76M96.06%-7.18M-122.75%-52.9M225.96%37.86M137.90%13.45M93.97%-5.59M-181.10%-182.08M87.82%-23.75M
End cash Position -69.25%32.02M-42.77%37.91M-6.33%49.45M-12.29%51.21M-12.29%51.21M26.75%104.1M-40.96%66.24M-64.25%52.79M-75.72%58.38M-75.72%58.38M
Free cash flow 0.61%-33.33M-98.62%-35.23M-33.97%-40.15M-7.02%-104.9M12.71%-23.66M-39.58%-33.54M27.58%-17.74M-33.82%-29.97M-175.03%-98.02M-22.77%-27.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday-0.48%